RxDoctor Payments Data

Tri le, MD

Family Medicine · Coldspring, TXNPI 1205848033

Payments from drug & device makers

$1,627in general payments, 2019–2025

Across 86 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$335
  • AstraZeneca$295
  • Astellas Pharma US Inc$249
  • Pfizer$155
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$139
  • Sunovion Pharmaceuticals Inc.$119
  • plus $335 from 11 others

What the payments were for

  • Food & beverage$1,46090%
  • Education$16710%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,627 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$152,430
Medicare patients
246
Services billed
4,410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide108$118,174
EliquisApixaban154$112,088
Trelegy ElliptaFluticasone/Umeclidin/Vilanter131$99,100
JanuviaSitagliptin Phosphate95$80,162
MounjaroTirzepatide58$77,331
JardianceEmpagliflozin80$70,546
TrulicityDulaglutide32$34,574
MyrbetriqMirabegron43$31,038
XareltoRivaroxaban32$20,566
NuedextaDextromethorphan Hbr/Quinidine26$20,389
LinzessLinaclotide14$14,878
JanumetSitagliptin Phos/Metformin Hcl14$14,490
FarxigaDapagliflozin Propanediol21$14,260
Combivent RespimatIpratropium/Albuterol Sulfate26$12,804
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$11,541

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$155$118,947169 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$335$117,883176 claims
Boehringer IngelheimJardiance, Combivent Respimat, Synjardy, Tradjenta$20$100,987130 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$295$33,20261 claims
Astellas Pharma US IncMyrbetriq$249$31,03843 claims
Johnson & JohnsonXarelto$18$20,56632 claims
Sumitomo Pharma America, Inc.Gemtesa$33$10,98911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Coldspring

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →